α1β2δ, a silent GABAAreceptor: recruitment by tracazolate and neurosteroids
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background and purpose: This study investigated the α 1 β 2 δ isoform of the GABA A receptor that is presumably expressed in the forebrain. The functional and pharmacological properties of this receptor combination are largely unknown. Experimental approach: We expressed α 1 β 2 δ GABA A receptors in Xenopus laevis oocytes. GABA‐activated currents, in the presence and absence of modulators, were recorded using the two‐electrode voltage clamp technique. Key results: The α 1 β 2 δ isoform of the GABA A receptor exhibited an extremely small GABA‐mediated current. Tracazolate increased the current amplitude evoked by a half‐maximal concentration (EC 50) of GABA by 59‐fold. The maximum current was increased 23‐fold in the presence of a saturating GABA concentration. Concomitant with the increase in the maximum, was a 4‐fold decrease in the EC 50. Finally, a mutation in the second transmembrane domain of the δ subunit that increases receptor efficacy (L286S), eliminated the increase in the maximum GABA‐activated current. The endogenous neurosteroid, tetrahydrodeoxycorticosterone (THDOC), also decreased the EC 50 and increased the maximum current amplitude, although to a lesser degree than that of tracazolate. Conclusions and implications: Taken all together, these findings indicate that the small GABA‐mediated currents in the absence of the modulator are due to a low efficacy for activation. In the absence of modulators, α 1 β 2 δ GABA receptors would be effectively silent and therefore contribute little to inhibition in the CNS. In the presence of tracazolate or endogenous neurosteroids however, this particular receptor isoform could exert a profound inhibitory influence on neuronal activity. British Journal of Pharmacology(2008)153, 1062–1071; doi:10.1038/sj.bjp.0707665; published online 21 January 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975 · cited 7×
“Upon exposure to THDOC or tracazolate, however, this receptor combination could exert a profound inhibitory influence on excitability in the CNS.”
BackgroundInfluentialFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244 · cited 1×
“It is abundant in cerebellar and dentate gyrus granule cells, some cortical areas, thalamic relay nuclei and the striatum (Benke et al., 1991; Laurie et al., 1992; Wisden et al., 1992; Fritschy and Mohler, 1995; Sperk et al., 1997; Pirker et al., 2000; Peng et al., 2002).”
BackgroundWhich GABAA-receptor subtypes really occur in the brain?
McKernan, R. M., & Whiting, P. J. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80023-3 · Cited by 1,222
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752 · cited 1×
“Recently, two domains have been identified and suggested to represent neurosteroid binding sites (Hosie et al., 2006).”
BackgroundNeurosteroids and GABAA receptor function
Lambert, J. J., Belelli, D., Hill-Venning, C., & Peters, J. A. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89058-6 · Cited by 746
Peng, Z., Hauer, B., Mihalek, R. M., Homanics, G. E., Sieghart, W., Olsen, R. W., & Houser, C. R. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10210 · Cited by 247 · cited 2×
“…role in the regulation of inhibition in the CNS by endogenous neurosteroids as well as behavioral responses to certain sedative/hypnotic and anxiolytic drugs (Mihalek et al., 1999; Peng et al., 2002; Wohlfarth et al., 2002; Bianchi and Macdonald, 2003; Wallner et al., 2003; Dibbens et al., 2004).”
BackgroundMechanism of action of benzodiazepines on GABA A receptors
Campo‐Soria, C., Chang, Y., & Weiss, D. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706796 · Cited by 212
Self-citationAkk, G., Bracamontes, J., & Steinbach, J. H. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0673e.x · Cited by 137 · cited 1×
“What is clear is that there is strong evidence that neurosteroids have multiple sites of action on the GABA receptor (Akk et al., 2001; Morris and Amin, 2004; Ueno et al., 2004; Akk et al., 2004b; Wardell et al., 2006; Hosie et al., 2007).”
Background
Cited by
Structure, Function, and Modulation of GABAA Receptors
Sigel, E., & Steinmann, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.386664 · Cited by 812
Extrasynaptic GABA A Receptors: Form, Pharmacology, and Function
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., & Cope, D. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-09.2009 · Cited by 464
“…anesthetics), barbiturates (Saxena and Macdonald, 1996; Feng et al., 2004), certain anesthetics (see Thalamic extrasynaptic GABAARs are a target for ethanol and volatile anesthetics), the nonbenzodiazepine anxiolytic tracazolate (Zheleznova et al., 2008), and protons (Feng and Macdonald, 2004).”
BackgroundNeurosteroids: Endogenous allosteric modulators of GABAA receptors
Lambert, J. J., Cooper, M. A., Simmons, R. D. J., Weir, C. J., & Belelli, D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.009 · Cited by 180
Milenkovic, I., Vasiljevic, M., Maurer, D., Höger, H., Klausberger, T., & Sieghart, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.019 · Cited by 62
“However, it has been shown recently, that the d subunit may also assemble with other subunits, like the a1 subunit, possibly creating receptors with special functions and localization (Glykys et al., 2007; Zheleznova et al., 2008).”
Metadata
- Authors
- Zheleznova, N., Sedelnikova, A., & Weiss, D. S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 153
- Issue
- 5
- Pages
- 1062-1071
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1594120948
- Cited by
- 55
- References
- 8
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.